Basilea Pharmaceutica AG (SWX:BSLN)
64.60
-1.00 (-1.52%)
Aug 21, 2026, 5:31 PM CET
Basilea Pharmaceutica AG Employees
Basilea Pharmaceutica AG had 200 employees as of June 30, 2026. The number of employees increased by 11 or 5.82% since the number was reported on December 31, 2025.
Employees
200
Change
11
Growth
5.82%
Revenue / Employee
1.24M CHF
Profits / Employee
261.92K CHF
Market Cap
801.24M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 200 | 11 | 5.82% |
| Dec 31, 2025 | 189 | 25 | 15.24% |
| Dec 31, 2024 | 164 | 17 | 11.56% |
| Dec 31, 2023 | 147 | 6 | 4.26% |
| Dec 31, 2022 | 141 | -13 | -8.44% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bachem Holding AG | 2,725 |
| Idorsia | 487 |
| Molecular Partners AG | 134 |
| Santhera Pharmaceuticals Holding AG | 94 |
| BioVersys AG | 33 |
| Newron Pharmaceuticals | 27 |
| Xlife Sciences AG | 20 |
| Addex Therapeutics | 3 |
Basilea Pharmaceutica AG News
- 4 days ago - Basilea Pharmaceutica AG Earnings Call Transcript: H1 2026 - Transcripts
- 4 days ago - Basilea Pharmaceutica AG Quarterly report: H1 2026 - Filings
- 4 days ago - Basilea Pharmaceutica AG Slides: H1 2026 - Filings
- 4 days ago - Basilea Pharmaceutica AG Earnings release: H1 2026 - Filings
- 17 days ago - Basilea Pharmaceutica AG Slides: Investor presentation - Filings
- 17 days ago - Basilea Receives BARDA Funding Of $5.4 Mln To Advance Antibiotic Combination In Treating UTIs - Nasdaq
- 24 days ago - Basilea Secures Fresh BARDA Support With $30M Tranche For Phase 3 Antifungal Fosmanogepix - Nasdaq
- 7 weeks ago - Basilea Pharmaceutica AG Slides: Investor presentation - Filings